Autonomix begins human poc clinical trial targeting multi-billion-dollar pancreatic cancer market

Site initiation completed for first study ever to evaluate radiofrequency (rf) ablation in a transvascular approach to reduce the pain associated with pancreatic cancer

AMIX Ratings Summary

AMIX Quant Ranking